Perindopril Erbumine
Perindopril Erbumine (CAS: 107133-36-8), also known as perindopril tert-butylamine, is the tert-butylamine salt of perindopril. Supplied as a solid, it is an orally active prodrug of perindoprilat. Following oral administration, conversion to perindoprilat produces the compound that inhibits angiotensin-converting enzyme, or ACE. Perindopril erbumine has been used as an active pharmaceutical ingredient in formulations for hypertension and coronary artery disease. Alongside this pharmaceutical role, the salt is handled as a pharmaceutical reference material and used in laboratory research involving the compound.
• Used as an active pharmaceutical ingredient in oral perindopril formulations for blood-pressure management and treatment of hypertension.
• Functions as a prodrug: after administration, perindopril is converted to perindoprilat, an angiotensin-converting enzyme (ACE) inhibitor.
• Formulations containing perindopril erbumine have also been used for coronary artery disease and other cardiovascular conditions.
• Supplied in research and pharmacopoeial reference contexts for pharmaceutical development and analytical work; follow the applicable product specification and handling requirements.
Product Name: Perindopril Erbumine
For global customers, we provide complete technical documentation to support product evaluation, regulatory compliance and safe handling during transportation and application.